

Five-year timeline for BASF SE (BAS.XETRA): major events, developments and context behind the stock's recent history.
View full stock analysis →2026 Oct 28–30
BASF reported strong Q3 2026 results and narrowed while raising full-year 2026 EBITDA-before-special-items guidance to €7.4–€7.8bn. The company confirmed progress on restructuring and portfolio measures, with exploratory talks reported about a possible takeover of Evonik. Disposals and strategic deals continued, including the Coatings sale to Carlyle and joint venture talks on PA6.
Investor perception shifted toward a credible near-term recovery driven by pricing and portfolio simplification. The market viewed results and tightened guidance as evidence that the "Winning Ways" restructuring and earlier disposals were beginning to boost earnings and cash generation. Evonik approach and rejection headlines created M&A speculation and volatility around strategic direction and potential consolidation in European chemicals [11][6][1][3].
Q3 2026 sales reached €16.4bn compared to €14.3bn in Q3 2025. Q3 2026 EBITDA before special items was €1.6bn, up 15 percent year-over-year [11][6].
2026 H1 (Jan–Jun) / Q2 2026 results (reported Jul 29, 2026)
BASF posted H1 and Q2 2026 results showing higher earnings in nearly all segments. The company reported a €3.5bn after-tax disposal gain from the sale of Coatings and raised its 2026 outlook. The successful ramp-up of the Zhanjiang Verbund site and further headcount reductions of approximately 7,000 full-time equivalents between January 2024 and June 2026 were highlighted.
Investors increasingly saw portfolio reshaping through disposals and the minority stake in standalone Coatings, plus asset ramp-ups, as de-risking and value-unlocking measures. The market moved from skepticism about structural turnaround to cautious optimism that portfolio and cost actions were producing tangible earnings and cash benefits [4][5].
H1 2026 sales were €33.2bn compared to €31.3bn in H1 2025. Q2 2026 sales reached €17.2bn, up €2.4bn year-over-year. The disposal gain after taxes from the Coatings sale of €3.5bn was included in results for the period [4][5].
2026 Feb 27 — Full-year 2025 results and Annual Report 2025
BASF published FY2025 results and the Report 2025 showing sales of €59.7bn against €61.4bn in 2024, and EBITDA before special items of €6.6bn against €7.2bn in 2024. Net income was €1.62bn. The company reported successful start-up of the Zhanjiang Verbund site and announced an agreement to sell Coatings, with material transactions announced in 2025 and closing activities ongoing. Planned acquisitions in Agricultural Solutions were announced, including AgBiTech on January 13, 2026, expected to close in H1 2026.
Following a difficult 2024–2025 period with lower upstream margins and currency headwinds, investor view was that BASF was executing structural actions through asset disposals, capex discipline, and cost savings to stabilize margins and improve free cash flow. This represented a shift from "value trap" fears toward cautious belief in a managed turnaround and re-positioning for growth, particularly in Ag and specialty materials [2][7][5].
FY 2025 sales were €59,657m. EBITDA before special items reached €6,554m. Free cash flow was €1,342m for FY 2025 and net income was €1,619m. FY 2026 EBITDA-before-special-items outlook was given as €6.2–€7.0bn at that time, later revised [2][5][7].
2025 Oct–Dec — Major portfolio transactions and Coatings carve-out
In October 2025, BASF reached an agreement with private equity firm Carlyle on a transaction to create a standalone Coatings company. BASF was to receive approximately €5.8bn in pre-tax proceeds and retain approximately 40 percent equity stake. On October 1, 2025, the sale of the Brazilian decorative paints business to Sherwin-Williams closed. Disposal gains were recognized in FY2025 reporting. The transaction progressed to closing phases in H1 2026.
The market treated accelerated portfolio rationalization as a key element of management's "value-enhancing" program. Investors began to re-rate parts of BASF as management demonstrated willingness to monetize lower-return businesses and concentrate on more profitable specialty and agricultural segments, supporting a strategic narrative of active portfolio management rather than passive cost cutting [5][1].
Announced pre-tax cash proceeds from the Coatings transaction were approximately €5.8bn. The disposal gain before taxes on the Brazilian decorative paints business was €664m, included in 2025 reporting. Coatings divestment proceeds affected FY2025 reporting and later cash flow [5][2].
2024 — Continued weak demand in Europe, restructuring and cost programs
Through 2024, BASF faced weaker demand and margin pressure in several commodity-exposed segments. The company announced restructuring and cost savings measures and reported lower EBITDA in FY2024 versus prior years. Capex discipline and efficiency improvements were prioritized while continuing large investments, including Zhanjiang and Geismar MDI expansion.
Investor perception during 2024 was mixed. Concern about European industrial softness and cyclical exposure, framed as a value-trap narrative for cyclical chemical names, was balanced by respect for BASF's capital allocation and long-term investments. Investors debated timing of the cyclical recovery and the payoff from large growth projects [5][2].
FY 2024 EBITDA before special items was €7.2bn, with FY 2025 showing a decline to €6.6bn. BASF disclosed capex intentions and large ongoing investments including the Geismar MDI expansion of approximately $1bn and Zhanjiang startup activity. Prior-year figures were restated around portfolio changes affecting Coatings [5][2].
2021–2023 — Pandemic aftermath, energy/commodity cycles, and strategic repositioning
From 2021–2022, recovery proceeded from the COVID downturn. 2022 saw significant volatility from energy and commodity prices, notably European energy costs, and disruption from Russia-Ukraine developments affecting feedstock, trading positions, and earnings. In 2023, management began stronger emphasis on portfolio strategy, capex prioritization, and launch of efficiency and value-creation programs such as "Winning Ways."
Investors moved from post-pandemic recovery optimism in 2021 to heightened concern in 2022 about cyclical and geopolitical risks. By 2023, the market began to expect more active management of the portfolio and cost base, framing BASF as a large cyclical chemicals group seeking to become more resilient and specialty-tilted rather than purely commodity-exposed [7][5].
BASF's earnings and margins showed large year-to-year swings across this period, with EBITDA before special items peaking in 2021–2022 and then falling toward 2024–2025 levels. Management publicly outlined a multi-year investment program of approximately €8.7bn for 2019–2028 including Zhanjiang and announced major projects such as the Zhanjiang Verbund and Geismar MDI expansion, along with portfolio reviews during these years [5][2].
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial